Santa Cruz Biotechnology supplies a comprehensive collection of STKLD1 monoclonal antibodies for research focused on understanding STKLD1's role in various biological processes. STKLD1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). STKLD1, or Serine/Threonine Kinase-Like Domain Containing 1, plays a significant role in cellular signaling pathways and influences cell growth and differentiation. Research has shown STKLD1's involvement in various cellular processes, making it a significant focus in cancer and disease studies. Investigating STKLD1 expression and activity patterns can reveal new therapeutic opportunities. Advanced research techniques and reliable detection methods are essential for uncovering STKLD1's biological significance. Multiple conjugation options are available, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC), enabling versatile experimental approaches. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of STKLD1's role in human health and disease.